# Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin

> **NCT03299296** · PHASE3 · UNKNOWN · sponsor: **Ahmed AbdelMoneim Hassan Ali** · enrollment: 100 (actual)

## Conditions studied

- Thromboses, Deep Vein
- Surgery--Complications

## Interventions

- **DRUG:** Rivaroxaban 10 Milligrams
- **DRUG:** Enoxaparin 40 Milligrams/0.4 Milliliters Prefilled Syringe

## Key facts

- **NCT ID:** NCT03299296
- **Lead sponsor:** Ahmed AbdelMoneim Hassan Ali
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2018-01-30
- **Final completion:** 2018-03-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03299296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03299296, "Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03299296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*